相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance
Felicity Newell et al.
CANCER CELL (2022)
Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis
Niklas Wrede et al.
PATHOLOGY RESEARCH AND PRACTICE (2022)
Tumor Intrinsic PD-L1 Promotes DNA Repair in Distinct Cancers and Suppresses PARP Inhibitor-Induced Synthetic Lethality
Anand V. R. Kornepati et al.
CANCER RESEARCH (2022)
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
Simon Fietz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Nivolumab Plus Ipilimumab for Treatment-Naive Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Jose Maria Piulats et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head & neck squamous cell carcinoma
Christopher Bockhorst et al.
EPIGENOMICS (2021)
CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
Niklas Kluemper et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab: a single-institution retrospective study
Kenjiro Namikawa et al.
MELANOMA RESEARCH (2020)
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Anja Wessely et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development
Carlos R. Figueiredo et al.
JOURNAL OF PATHOLOGY (2020)
Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer
Kyungsoo Kim et al.
GENOME MEDICINE (2020)
The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas
Luka de Vos et al.
EPIGENETICS (2020)
Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours
Peter A. Johansson et al.
NATURE COMMUNICATIONS (2020)
LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
Niklas Kluemper et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Prognostic and predictive value ofPD-L2DNA methylation and mRNA expression in melanoma
Friederike Hoffmann et al.
CLINICAL EPIGENETICS (2020)
Single-cell multiomics: technologies and data analysis methods
Jeongwoo Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas
Philipp Lingohr et al.
EPIGENOMICS (2019)
BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma
Raunak Shrestha et al.
GENOME MEDICINE (2019)
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
Leanne De Koning et al.
CANCERS (2019)
BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas
Matthew G. Field et al.
CLINICAL CANCER RESEARCH (2019)
TOX is a critical regulator of tumour-specific T cell differentiation
Andrew C. Scott et al.
NATURE (2019)
TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion
Omar Khan et al.
NATURE (2019)
BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers
Jeffim N. Kuznetsov et al.
SCIENCE ADVANCES (2019)
Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)
Dirk Schadendorf et al.
EUROPEAN JOURNAL OF CANCER (2019)
Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
Kalijn Fredrike Bol et al.
CANCERS (2019)
PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival
Goran Micevic et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
Epigenome-wide analysis reveals specific DNA hypermethylation of T cells during human hematopoietic differentiation
J. Ramon Tejedor et al.
EPIGENOMICS (2018)
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
Lea Kristin Roever et al.
EBIOMEDICINE (2018)
CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients
Diane Goltz et al.
JCI INSIGHT (2018)
Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4
Xuan Mo et al.
CANCER RESEARCH (2018)
Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands
M. K. van der Kooij et al.
ACTA ONCOLOGICA (2017)
PD-L1 (CD274) promoter methylation predicts survival in patients with acute myeloid leukemia
D. Goltz et al.
LEUKEMIA (2017)
PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients
Diane Goltz et al.
ONCOIMMUNOLOGY (2017)
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition
Markus V. Heppt et al.
EUROPEAN JOURNAL OF CANCER (2017)
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
Smita S. Chandran et al.
LANCET ONCOLOGY (2017)
Effector CD8 T cells dedifferentiate into long-lived memory cells
Ben Youngblood et al.
NATURE (2017)
PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
Diane Goltz et al.
ONCOTARGET (2017)
Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
Sebastian Marwitz et al.
CLINICAL EPIGENETICS (2017)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation
Hazem E. Ghoneim et al.
CELL (2017)
Epigenomic Profiling of Human CD4+ T Cells Supports a Linear Differentiation Model and Highlights Molecular Regulators of Memory Development
Pawel Durek et al.
IMMUNITY (2016)
The use of pembrolizumab for the treatment of metastatic uveal melanoma
Lisa A. Kottschade et al.
MELANOMA RESEARCH (2016)
Toward a Shared Vision for Cancer Genomic Data
Robert L. Grossman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The epigenetic landscape of T cell exhaustion
Debattama R. Sen et al.
SCIENCE (2016)
Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade
Kristen E. Pauken et al.
SCIENCE (2016)
PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Heidrun Gevensleben et al.
ONCOTARGET (2016)
Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Diane Goltz et al.
ONCOIMMUNOLOGY (2016)
Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma
Ioannis Karydis et al.
ONCOIMMUNOLOGY (2016)
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth
Sonja Kleffel et al.
CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Comprehensive molecular profiling of lung adenocarcinoma
Eric A. Collisson et al.
NATURE (2014)
Coordinated Changes in DNA Methylation in Antigen-Specific Memory CD4 T Cells
Shin-ichi Hashimoto et al.
JOURNAL OF IMMUNOLOGY (2013)
Plasticity of DNA methylation in mouse T cell activation and differentiation
Yan Li et al.
BMC MOLECULAR BIOLOGY (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Functions of DNA methylation: islands, start sites, gene bodies and beyond
Peter A. Jones
NATURE REVIEWS GENETICS (2012)
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Arun D. Singh et al.
OPHTHALMOLOGY (2011)
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Johanna C. Scheuermann et al.
NATURE (2010)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
BRCA1-Associated Protein 1 Interferes with BRCA1/BARD1 RING Heterodimer Activity
Hiroyuki Nishikawa et al.
CANCER RESEARCH (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Very long-term prognosis of patients with malignant uveal melanoma
E Kujala et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
分享论文
